Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
G.B. John Mancini(Cedars-Sinai Medical Center), Bertram Pitt(Bayer (Germany)), Harry Haber(Dalhousie University), Michael Klibaner(Dalhousie University), Andrew C. G. Uprichard(Dalhousie University), Harald Mudra(Dalhousie University), Blair J. O’Neill(Dalhousie University), Carlos Macaya(Hospital Clínico San Carlos), Thomas F. Lu ̈scher(University Hospital of Zurich), Carl J. Pepine(Cedars-Sinai Medical Center), Thomas J. Wargovich(Dalhousie University), Gregory C. Henry(Dalhousie University), Ronald G. Carere(Dalhousie University), Anthony L. Pucillo(Dalhousie University)
Cited by 1,060
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
The Seattle Heart Failure Model
|Circulation|2006|2k